LONDON, August 26, 2010 /PRNewswire-FirstCall/ -- Hikma Pharmaceuticals reports half year profit growth and raises gross margin guidance.
In a video interview on www.cantos.com, Hikma CEO Said Darwazah says a good performance at the company's three divisions supported the results. "All three engines have been performing quite well, to give us these fantastic results."
The Generic drugmaker's Chief Financial Officer, Bassam Kaanan, added that the company was financially strong. "We do have plenty of room to finance our organic growth and also to move very aggressively on our acquisition strategy."
The interview and transcript are available now on http://www.cantos.com.
Cantos.com, the online financial broadcaster, features in-depth interviews, documentaries and webcasts with senior company executives. If you would like to contact us, please email firstname.lastname@example.org or phone +44-207-936-1352.
SOURCE Hikma Pharmaceuticals